Table 1.
Genetic variants showing significant associations with OS risk in main meta-analyses.
Gene | Variant | Allelic a | Ethnicity | Number evaluation | Genetic models | MAF | Effect model | Risk of meta-analysis | Venice Criteria c | FPRP values d | Credibility of evidence | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Studies | Cases/controls | OR b (95%CI) | I2 | P Q | P value | ||||||||||
APE1 | rs1760944 | T>G | Asian | 2 | 378/616 | Allelic | 0.442 | Fixed | 0.692 (0.574–0.834) | 0 | 0.701 | <0.001 | BAA | 0.003 | Strong |
Dominant | Fixed | 0.610 (0.468–0.796) | 0 | 0.748 | <0.001 | BAA | 0.020 | Strong | |||||||
Recessive | Fixed | 0.642 (0.451–0.914) | 0 | 0.867 | 0.014 | BAA | 0.388 | Weak | |||||||
BCAS1 | rs3787547 | G>A | Asian | 2 | 1300/1300 | Allelic | 0.300 | Fixed | 1.222 (1.088–1.373) | 0 | 0.703 | 0.001 | AAA | 0.014 | Strong |
Dominant | Fixed | 1.295 (1.110–1.511) | 0 | 0.694 | 0.001 | AAA | 0.020 | Strong | |||||||
CTLA-4 | rs231775 | A>G | Overall | 4 | 660/754 | Allelic | 0.623 | Fixed | 0.725 (0.620–0.846) | 0 | 0.96 | <0.001 | AAA | 0.001 | Strong |
Dominant | Fixed | 0.491 (0.360–0.668) | 0 | 0.981 | <0.001 | AAA | 0.004 | Strong | |||||||
Recessive | Fixed | 0.748 (0.596–0.938) | 29.9% | 0.233 | 0.012 | BBC | 0.212 | Weak | |||||||
Asian | 3 | 594/629 | Allelic | 0.672 | Fixed | 0.723 (0.613–0.853) | 0 | 0.862 | <0.001 | AAA | 0.003 | Strong | |||
Dominant | Fixed | 0.506 (0.354–0.722) | 0 | 0.97 | <0.001 | AAA | 0.049 | Strong | |||||||
Recessive | Fixed | 0.717 (0.569–0.903) | 0 | 0.711 | 0.005 | BAA | 0.109 | Moderate | |||||||
rs5742909 | C>T | Asian | 3 | 486/533 | Recessive | Fixed | 2.046 (1.028–4.073) | 0.0% | 0.591 | 0.042 | CAC | 0.807 | Weak | ||
ERCC3 | rs4150441 | T>C | Asian | 2 | 522/1047 | Dominant | Fixed | 0.519 (0.357–0.755) | 60.1% | 0.113 | 0.001 | ACA | 0.108 | Moderate | |
rs4150506 | G>A | Asian | 2 | 522/1047 | Allelic | 0.230 | Fixed | 1.331 (1.123–1.576) | 0 | 0.581 | 0.001 | BAA | 0.019 | Strong | |
Dominant | Fixed | 1.348 (1.089–1.667) | 0 | 0.775 | 0.006 | BAA | 0.117 | Moderate | |||||||
Recessive | Fixed | 1.622 (1.110–2.370) | 0 | 0.498 | 0.012 | BAA | 0.408 | Weak | |||||||
HOTAIR | rs7958904 | C>G | Asian | 2 | 900/900 | Allelic | 0.710 | Fixed | 1.294 (1.115–1.501) | 0 | 0.736 | 0.001 | AAA | 0.013 | Strong |
Dominant | Fixed | 1.636 (1.154–2.321) | 0 | 0.961 | 0.006 | AAA | 0.260 | Moderate | |||||||
Recessive | Fixed | 1.298 (1.078–1.564) | 0 | 0.768 | 0.006 | BAA | 0.110 | Moderate | |||||||
rs874945 | C>T | Asian | 2 | 900/900 | Allelic | 0.189 | Fixed | 1.183 (1.006–1.393) | 17.4% | 0.271 | 0.042 | BAA | 0.455 | Weak | |
IL-10 | rs1800896 | T>C | Overall | 2 | 340/420 | Allelic | 0.391 | Fixed | 1.326 (1.060–1.657) | 0 | 0.557 | 0.013 | BAA | 0.224 | Weak |
Dominant | Fixed | 1.398 (1.009–1.936) | 33.9% | 0.219 | 0.044 | BBA | 0.556 | Weak | |||||||
IL-6 | rs1800795 | C>G | Asian | 2 | 322/322 | Allelic | 0.750 | Random | 0.563 (0.445–0.712) | 0 | 0.805 | <0.001 | BAA | 0.000 | Strong |
Recessive | Random | 0.420 (0.268–0.659) | 47.6% | 0.167 | <0.001 | BBA | 0.121 | Moderate | |||||||
IL-8 | rs4073 | A>T | Asian | 2 | 299/299 | Allelic | 0.776 | Fixed | 0.625 (0.483–0.809) | 0 | 0.793 | <0.001 | BAA | 0.021 | Strong |
Dominant | Fixed | 0.598 (0.366–0.975) | 0 | 0.949 | 0.039 | BAA | 0.692 | Weak | |||||||
Recessive | Fixed | 0.590 (0.424–0.819) | 0 | 0.823 | 0.002 | BAA | 0.116 | Moderate | |||||||
MTAP | rs7023329 | A>G | Asian | 2 | 392/1578 | Allelic | 0.512 | Fixed | 0.712 (0.615–0.844) | 0 | 0.540 | <0.001 | AAA | 0.002 | Strong |
Dominant | Fixed | 0.650 (0.510–0.828) | 0 | 0.439 | <0.001 | AAA | 0.022 | Strong | |||||||
Recessive | Fixed | 0.641 (0.484–0.848) | 0 | 0.855 | 0.002 | BAA | 0.082 | Moderate | |||||||
rs7027989 | A>G | Asian | 2 | 392/1578 | Allelic | 0.824 | Fixed | 0.761 (0.627–0.923) | 0 | 0.905 | 0.006 | AAA | 0.104 | Strong | |
Recessive | Fixed | 0.757 (0.601–0.954) | 0 | 0.760 | 0.018 | AAA | 0.288 | Moderate | |||||||
Dominant | Fixed | 0.557 (0.328–0.945) | 0 | 0.751 | 0.030 | AAA | 0.693 | Moderate | |||||||
PRKCG | rs454006 | T>C | Asian | 2 | 998/998 | Allelic | 0.293 | Fixed | 1.347 (1.178–1.539) | 0 | 0.826 | <0.001 | AAA | 0.000 | Strong |
Dominant | Fixed | 1.204 (1.010–1.437) | 15.4% | 0.277 | 0.039 | AAA | 0.432 | Moderate | |||||||
Recessive | Fixed | 1.989 (1.536–2.575) | 0 | 0.596 | <0.001 | BAA | 0.000 | Strong | |||||||
RECQL5 | rs820196 | T>C | Asian | 2 | 397/441 | Allelic | 0.340 | Fixed | 1.445 (1.186–1.762) | 0 | 0.742 | <0.001 | BAA | 0.008 | Strong |
Dominant | Fixed | 1.487 (1.118–1.976) | 0 | 0.844 | 0.006 | BAA | 0.184 | Moderate | |||||||
Recessive | Fixed | 2.153 (1.409–3.289) | 0 | 0.700 | <0.001 | BAA | 0.135 | Moderate | |||||||
TNF-α | rs1800629 | G>A | Overall | 2 | 160/259 | Allelic | 0.183 | Fixed | 1.743 (1.245–2.440) | 0 | 0.582 | 0.001 | BAA | 0.107 | Moderate |
Dominant | Fixed | 1.640 (1.065–2.524) | 0 | 0.427 | 0.025 | BAA | 0.576 | Weak | |||||||
Recessive | Fixed | 3.306 (1.541–7.093) | 0 | 0.588 | 0.002 | CAA | 0.657 | Weak | |||||||
TP53 | rs1042522 | G>C | Overall | 3 | 515/744 | Allelic | 0.499 | Fixed | 0.738 (0.618–0.881) | 0.0% | 0.754 | 0.001 | AAA | 0.017 | Strong |
Dominant | Fixed | 0.591 (0.445–0.784) | 14.5% | 0.310 | <0.001 | BAA | 0.024 | Strong | |||||||
G>C | Caucasian | 2 | 305/324 | Allelic | 0.342 | Fixed | 0.764 (0.584–0.999) | 0.0% | 0.503 | 0.049 | BAA | 0.526 | Weak | ||
Dominant | Fixed | 0.534 (0.364–0.783) | 47.4% | 0.168 | 0.001 | BBA | 0.163 | Moderate | |||||||
VEGF | rs1570360 | A>G | Asian | 3 | 527/692 | Allelic | 0.254 | Fixed | 1.229 (1.025–1.475) | 0 | 0.774 | 0.026 | BAC | 0.341 | Weak |
rs2010963 | C>G | Asian | 7 | 1489/1867 | Allelic | 0.338 | Random | 1.249 (1.089–1.432) | 46.4% | 0.083 | 0.001 | ABA | 0.027 | Strong | |
Dominant | Fixed | 1.393 (1.190–1.630) | 0 | 0.504 | <0.001 | AAA | 0.001 | Strong | |||||||
Recessive | Fixed | 1.294 (1.098–1.524) | 34.8% | 0.163 | 0.002 | BBA | 0.038 | Strong | |||||||
rs3025039 | C>T | Asian | 8 | 1671/2049 | Allelic | 0.230 | Fixed | 1.248 (1.120–1.391) | 0 | 0.941 | <0.001 | AAA | 0.001 | Strong | |
Dominant | Fixed | 1.222 (1.066–1.399) | 0 | 0.997 | 0.004 | AAC | 0.065 | Weak | |||||||
Recessive | Fixed | 1.596 (1.253–2.032) | 0 | 0.702 | <0.001 | BAA | 0.009 | Strong | |||||||
rs699947 | A>C | Asian | 4 | 709/874 | Allelic | 0.679 | Fixed | 0.713 (0.615–0.827) | 0 | 0.593 | <0.001 | AAA | 0.000 | Strong | |
Dominant | Fixed | 0.611 (0.462–0.810) | 0 | 0.776 | 0.001 | AAA | 0.041 | Strong | |||||||
Recessive | Fixed | 0.685 (0.559–0.840) | 0 | 0.687 | <0.001 | BAA | 0.009 | Strong | |||||||
rs833061 | C>T | Asian | 2 | 358/358 | Allelic | 0.624 | Fixed | 0.788 (0.638–0.974) | 34.6% | 0.216 | 0.027 | BBA | 0.358 | Weak | |
VMP1 | rs1295925 | T>C | Asian | 2 | 1300/1300 | Allelic | 0.450 | Fixed | 0.847 (0.759–0.945) | 0 | 0.597 | 0.003 | AAA | 0.053 | Strong |
Dominant | Fixed | 0.767 (0.651–0.902) | 0 | 0.646 | 0.001 | AAA | 0.026 | Strong | |||||||
XRCC1 | rs25487 | T>C | Asian | 2 | 318/523 | Allelic | 0.481 | Fixed | 1.405 (1.132–1.745) | 0 | 0.433 | 0.002 | BAA | 0.052 | Moderate |
Dominant | Fixed | 1.488 (1.055–2.099) | 0 | 0.902 | 0.024 | BAA | 0.463 | Weak | |||||||
Recessive | Fixed | 1.564 (1.114–2.195) | 50.1% | 0.157 | 0.010 | BCA | 0.313 | Weak | |||||||
XRCC3 | rs861539 | G>A | Asian | 2 | 288/440 | Allelic | 0.272 | Fixed | 1.572 (1.252–1.975) | 0 | 0.882 | <0.001 | BAA | 0.006 | Strong |
Dominant | Fixed | 1.573 (1.161–2.133) | 0 | 0.902 | 0.003 | BAA | 0.151 | Moderate | |||||||
Recessive | Fixed | 2.230 (1.395–3.566) | 0 | 0.896 | 0.001 | CAA | 0.240 | Weak |
APE1, apurinic/apyrimidinic endodeoxyribonuclease 1; BCAS1, brain enriched myelin associated protein 1; CTLA4, cytotoxic T-lymphocyte associated protein 4; ERCC3, excision repair cross-complementation 3; HOTAIR, HOX transcript antisense RNA; IL-10, interleukin-10; IL-6, interleukin-6; IL-8, interleukin-8; MTAP, methylthioadenosine phosphorylase; PRKCG, protein kinase C gamma; RECQL5, RecQ like helicase 5; TNF-α, tumor necrosis factor α; TP53, tumor protein p53; VEGF, vascular endothelial growth factor A; VMP1, vacuole membrane protein 1; XRCC1, X-ray repair cross complementing 1; XRCC3, X-ray repair cross complementing 3; A, adenine; C, cytosine; G, guanine; T, thymine; OR, odds ratio; CI, confidence interval; MAF, minor allelic frequency in control; NA, not applicable; FPRP, false positive report probability.
Allelic: Minor allelic (bold) versus major allelic (reference).
OR: OR < 1, decrease the susceptibility of OS (protective factor); OR > 1, increase the susceptibility of OS (susceptive factor).
Venice Criteria grades are for the amount of evidence, replication of the association, and protection from bias.
The prior probability of FPRP is 0.05 and the FPRP level of noteworthiness is 0.20.